Hypoxic	0	7	O
induction	8	17	O
of	18	20	O
HIF	21	24	B-Gene_or_gene_product
-	24	25	I-Gene_or_gene_product
1alpha	25	31	I-Gene_or_gene_product
and	32	35	O
VEGF	36	40	B-Gene_or_gene_product
expression	41	51	O
in	52	54	O
head	55	59	B-Cell
and	60	63	I-Cell
neck	64	68	I-Cell
squamous	69	77	I-Cell
cell	78	82	I-Cell
carcinoma	83	92	I-Cell
lines	93	98	I-Cell
is	99	101	O
mediated	102	110	O
by	111	113	O
stress	114	120	O
activated	121	130	O
protein	131	138	O
kinases	139	146	O
.	146	147	O

Solid	149	154	B-Pathological_formation
tumors	155	161	I-Pathological_formation
must	162	166	O
establish	167	176	O
a	177	178	O
blood	179	184	B-Organism_substance
supply	185	191	O
in	192	194	O
order	195	200	O
to	201	203	O
proliferate	204	215	O
and	216	219	O
grow	220	224	O
.	224	225	O

Cancer	226	232	B-Cell
cells	233	238	I-Cell
secrete	239	246	O
soluble	247	254	O
factors	255	262	O
which	263	268	O
can	269	272	O
induce	273	279	O
proliferation	280	293	O
and	294	297	O
migration	298	307	O
of	308	310	O
capillary	311	320	B-Cell
endothelial	321	332	I-Cell
cells	333	338	I-Cell
.	338	339	O

Among	340	345	O
the	346	349	O
most	350	354	O
potent	355	361	O
of	362	364	O
the	365	368	O
angiogenic	369	379	O
factors	380	387	O
is	388	390	O
vascular	391	399	B-Gene_or_gene_product
endothelial	400	411	I-Gene_or_gene_product
growth	412	418	I-Gene_or_gene_product
factor	419	425	I-Gene_or_gene_product
(	426	427	O
VEGF	427	431	B-Gene_or_gene_product
)	431	432	O
.	432	433	O

Increased	434	443	O
VEGF	444	448	B-Gene_or_gene_product
expression	449	459	O
by	460	462	O
malignant	463	472	O
tumors	473	479	B-Pathological_formation
has	480	483	O
been	484	488	O
associated	489	499	O
with	500	504	O
high	505	509	O
vascularity	510	521	O
,	521	522	O
increased	523	532	O
cancer	533	539	B-Cell
cell	540	544	I-Cell
growth	545	551	O
,	551	552	O
and	553	556	O
lymph	557	562	B-Multi-tissue_structure
node	563	567	I-Multi-tissue_structure
metastasis	568	578	O
.	578	579	O

Reduced	580	587	O
oxygen	588	594	B-Drug_or_compound
tension	595	602	O
has	603	606	O
been	607	611	O
shown	612	617	O
to	618	620	O
increase	621	629	O
VEGF	630	634	B-Gene_or_gene_product
production	635	645	O
by	646	648	O
induction	649	658	O
of	659	661	O
the	662	665	O
transcription	666	679	O
factor	680	686	O
hypoxia	687	694	B-Gene_or_gene_product
inducible	695	704	I-Gene_or_gene_product
factor	705	711	I-Gene_or_gene_product
1	712	713	I-Gene_or_gene_product
alpha	714	719	I-Gene_or_gene_product
(	720	721	O
HIF	721	724	B-Gene_or_gene_product
-	724	725	I-Gene_or_gene_product
1alpha	725	731	I-Gene_or_gene_product
)	731	732	O
.	732	733	O

The	734	737	O
mechanisms	738	748	O
by	749	751	O
which	752	757	O
hypoxic	758	765	O
tumor	766	771	B-Pathological_formation
environments	772	784	O
induce	785	791	O
HIF	792	795	B-Gene_or_gene_product
-	795	796	I-Gene_or_gene_product
1alpha	796	802	I-Gene_or_gene_product
and	803	806	O
VEGF	807	811	B-Gene_or_gene_product
expression	812	822	O
are	823	826	O
largely	827	834	O
unknown	835	842	O
.	842	843	O

Jun	844	847	B-Gene_or_gene_product
N	848	849	I-Gene_or_gene_product
terminal	850	858	I-Gene_or_gene_product
kinase	859	865	I-Gene_or_gene_product
(	866	867	O
JNK1	867	871	B-Gene_or_gene_product
)	871	872	O
and	873	876	O
p38	877	880	B-Gene_or_gene_product
kinase	881	887	I-Gene_or_gene_product
are	888	891	O
activated	892	901	O
by	902	904	O
a	905	906	O
variety	907	914	O
of	915	917	O
stress	918	924	O
stimuli	925	932	O
.	932	933	O

To	934	936	O
determine	937	946	O
if	947	949	O
hypoxic	950	957	O
activation	958	968	O
of	969	971	O
these	972	977	O
stress	978	984	O
activated	985	994	O
protein	995	1002	O
kinases	1003	1010	O
regulated	1011	1020	O
HIF	1021	1024	B-Gene_or_gene_product
-	1024	1025	I-Gene_or_gene_product
1alpha	1025	1031	I-Gene_or_gene_product
and	1032	1035	O
VEGF	1036	1040	B-Gene_or_gene_product
expression	1041	1051	O
,	1051	1052	O
we	1053	1055	O
assayed	1056	1063	O
JNK1	1064	1068	B-Gene_or_gene_product
and	1069	1072	O
p38	1073	1076	B-Gene_or_gene_product
activity	1077	1085	O
in	1086	1088	O
squamous	1089	1097	B-Cell
cell	1098	1102	I-Cell
carcinoma	1103	1112	I-Cell
(	1113	1114	I-Cell
SCC	1114	1117	I-Cell
)	1117	1118	I-Cell
lines	1119	1124	I-Cell
grown	1125	1130	O
under	1131	1136	O
normoxic	1137	1145	O
or	1146	1148	O
hypoxic	1149	1156	O
conditions	1157	1167	O
.	1167	1168	O

Hypoxia	1169	1176	O
rapidly	1177	1184	O
induced	1185	1192	O
both	1193	1197	O
JNK1	1198	1202	B-Gene_or_gene_product
and	1203	1206	O
p38	1207	1210	B-Gene_or_gene_product
activity	1211	1219	O
in	1220	1222	O
these	1223	1228	O
cells	1229	1234	B-Cell
.	1234	1235	O

This	1236	1240	O
activation	1241	1251	O
correlated	1252	1262	O
with	1263	1267	O
induction	1268	1277	O
of	1278	1280	O
HIF	1281	1284	B-Gene_or_gene_product
-	1284	1285	I-Gene_or_gene_product
1alpha	1285	1291	I-Gene_or_gene_product
expression	1292	1302	O
and	1303	1306	O
DNA	1307	1310	O
binding	1311	1318	O
activity	1319	1327	O
which	1328	1333	O
was	1334	1337	O
blocked	1338	1345	O
by	1346	1348	O
the	1349	1352	O
p38	1353	1356	B-Gene_or_gene_product
inhibitor	1357	1366	O
SB203580	1367	1375	B-Drug_or_compound
.	1375	1376	O

Hypoxia	1377	1384	O
also	1385	1389	O
increased	1390	1399	O
VEGF	1400	1404	B-Gene_or_gene_product
production	1405	1415	O
by	1416	1418	O
SCC	1419	1422	B-Cell
lines	1423	1428	I-Cell
,	1428	1429	O
which	1430	1435	O
was	1436	1439	O
inhibited	1440	1449	O
by	1450	1452	O
treatment	1453	1462	O
with	1463	1467	O
SB203580	1468	1476	B-Drug_or_compound
.	1476	1477	O

Overexpression	1478	1492	O
of	1493	1495	O
JNK1	1496	1500	B-Gene_or_gene_product
or	1501	1503	O
p38	1504	1507	B-Gene_or_gene_product
was	1508	1511	O
sufficient	1512	1522	O
to	1523	1525	O
induce	1526	1532	O
HIF	1533	1536	B-Gene_or_gene_product
-	1536	1537	I-Gene_or_gene_product
1alpha	1537	1543	I-Gene_or_gene_product
and	1544	1547	O
VEGF	1548	1552	B-Gene_or_gene_product
expression	1553	1563	O
.	1563	1564	O

These	1565	1570	O
results	1571	1578	O
indicate	1579	1587	O
that	1588	1592	O
induction	1593	1602	O
of	1603	1605	O
SAPKs	1606	1611	B-Gene_or_gene_product
by	1612	1614	O
hypoxia	1615	1622	O
regulates	1623	1632	O
HIF	1633	1636	B-Gene_or_gene_product
-	1636	1637	I-Gene_or_gene_product
1alpha	1637	1643	I-Gene_or_gene_product
and	1644	1647	O
VEGF	1648	1652	B-Gene_or_gene_product
expression	1653	1663	O
in	1664	1666	O
head	1667	1671	B-Cell
and	1672	1675	I-Cell
neck	1676	1680	I-Cell
carcinoma	1681	1690	I-Cell
cell	1691	1695	I-Cell
lines	1696	1701	I-Cell
.	1701	1702	O

